- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02550353
Changes Between Lenticule Extraction and Femtosecond Laser-assisted Laser in Situ Keratomileusis
Comparison of Early Changes in Ocular Surface and Inflammatory Mediators Between Lenticule Extraction and Femtosecond Laser-assisted Laser in Situ Keratomileusis
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Over the past few years, laser in situ keratomileusis with a femtosecond laser-created flap (FS-LASIK)has been a popular ophthalmic procedure for the correction of refractive error. This first all-in-one FS-laser system was designed to perform the refractive lenticule extraction (ReLEx) procedures, femtosecond lenticule extraction (FLEx).They have the same feature: corneal flap.
Ocular surface disruption during corneal refractive surgery is commonly considered to be closely related to the development of dry eye. Multiple etiologies contribute to this ocular surface disruption, including the flap creation and stromal ablation involved in previous refractive surgery techniques. Corneal nerve damage has been considered the main cause of dry eye, due to disrupted afferent sensory nerves, reduced blink reflex, and increased tear evaporation leading to tear film instability. In addition, postoperative inflammatory mediator fluctuations are also a key factor related to ocular surface damage. Extensive research has described the effects of cytokines, chemokines and growth factors in modulating corneal wound healing, cell migration, and apoptosis on the ocular surface after refractive surgery.
This prospective clinical study is going to assess the short-term changes in ocular surface measures and tear inflammatory mediators after lenticule extraction (FLEx) and femtosecond laser-assisted laser in situ keratomileusis (FS-LASIK) procedures.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Hainan
-
Haikou, Hainan, China, 570311
- Hainan Eye Hospital, Zhongshan Ophthalmic Center of Sun Yat-sen University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- minimum age of 18 years(range from 18 year to 25 years)
- corneal thickness 500 μm with calculated residual stromal bed after treatment greater than 300 μm
- preoperative spherical equivalent refraction between- 2.00 diopter (D) and -6.50 D.preoperative cylindrical equivalent refraction between -0.25 D and -1.50 D.
- preoperative corneal curvature from 41.0 D to 46.0 D with a regular topographic pattern monocular best corrected visual acuity of 20/20 or better and stable refractive error (less than 0.5 D change) for 24 months before surgery。
Exclusion Criteria:
- systemic disease that contraindicated the surgery (such as diabetes, glaucoma and systemic collagen vascular disease)
- corneal abnormality or disease.
- a history of tear supplement usage or contact lens wear during the past year.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: lenticule extraction
The patients in this group chose to receive the lenticule extraction surgery
|
Four femtosecond incisions were created in succession: the posterior surface of the refractive lenticule (spiral in), the lenticule border, the anterior surface of the refractive lenticule (spiral out), and the corneal flap in the superior region.
After the suction was released, the flap was opened using a thin, blunt spatula and the free refractive lenticule was subsequently grasped with a forceps and extracted, after which the flap was repositioned carefully.
|
|
Experimental: FS assisted laser in situ keratomileusis
The patients in this group chose to receive the femtosecond laser-assisted laser in situ keratomileusis surgery.
|
track distance and spot distance were 3.0 μm during flap creation and 1.5 μm during flap side-cutting.
The flap diameter was 8.0 mm, and flap thickness was set to 105 μm.
Side-cut angle and hinge angle were 90°and 50° respectively.
The flaps were created by laser scanning in spirals from the periphery to the center of the pupil.
An excimer laser system was used in the subsequent ablation of the stromal bed with a 6.0 mm optical zone.
Once the excimer ablation was completed, the flap was repositioned in a similar fashion as in routine LASIK.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Schirmer I test
Time Frame: up to 1month after surgery
|
up to 1month after surgery
|
|
corneal fluorescein staining
Time Frame: up to 1month after surgery
|
up to 1month after surgery
|
|
noninvasive tear breakup time
Time Frame: up to 1month after surgery
|
up to 1month after surgery
|
|
ocular surface disease index
Time Frame: up to 1month after surgery
|
up to 1month after surgery
|
|
central corneal sensitivity
Time Frame: up to 1month after surgery
|
up to 1month after surgery
|
|
tear meniscus height
Time Frame: up to 1month after surgery
|
up to 1month after surgery
|
|
Interleukin-1α
Time Frame: up to 1month after surgery
|
up to 1month after surgery
|
|
tumor necrosis factor-α
Time Frame: up to 1month after surgery
|
up to 1month after surgery
|
|
nerve growth factor
Time Frame: up to 1month after surgery
|
up to 1month after surgery
|
|
interferon-γ
Time Frame: up to 1month after surgery
|
up to 1month after surgery
|
|
transforming growth factor-β1
Time Frame: up to 1month after surgery
|
up to 1month after surgery
|
|
matrix metalloproteinase-9
Time Frame: up to 1month after surgery
|
up to 1month after surgery
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Correlation Between Inflammatory Mediators and Ocular Surface Changes
Time Frame: up to 1month after surgery
|
up to 1month after surgery
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Xingwu Zhong, MD,PhD, Hainan Eye Hospital, Zhongshan Ophthalmic Center of Sun Yat-sen University
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2015-002
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Astigmatism
-
Bausch & Lomb IncorporatedNot yet recruiting
-
Ohio State UniversityAlcon ResearchRecruitingAstigmatism BilateralUnited States
-
Ohio State UniversityCompletedAstigmatism BilateralUnited States
-
CooperVision, Inc.Completed
-
Cairo UniversityUnknown
-
Assiut UniversityCompleted
-
Ashford and St. Peter's Hospitals NHS TrustBausch & Lomb IncorporatedUnknown
-
Carl Zeiss Meditec, Inc.CompletedMixed AstigmatismUnited States
-
Johnson & Johnson Vision Care, Inc.Completed
Clinical Trials on lenticule extraction
-
Second Affiliated Hospital of Nanchang UniversityCompletedMyopia | Small-incision Lenticule Extraction (SMILE) SurgeryChina
-
Tilganga Institute of OphthalmologyLondon Vision ClinicUnknown
-
Taipei Nobel Eye ClinicCompletedRefractive Errors | AstigmatismTaiwan
-
Singapore Eye Research InstituteRecruiting
-
Yifeng YuCompletedMyopia | Small-incision Lenticule Extraction (SMILE) SurgeryChina
-
Ziemer Ophthalmic Systems AGTigermed Consulting Co., LtdRecruitingMyopic AstigmatismChina
-
Odense University HospitalAarhus University HospitalCompleted
-
Singapore National Eye CentreUnknownAstigmatism | Myopia | HypermetropiaSingapore
-
University of BernNot yet recruiting
-
Hoopes VisionAlcon ResearchActive, not recruitingAstigmatism | MyopiaUnited States